Medical firm's OLO device, which analyzes blood samples in minutes, will be installed in 9 Emirati medical centers, then in other areas of Gulf region, company says
Investors in Sight Diagnostics include US's Koch Disruptive Technologies, Hong Kong-based Longliv Ventures and OurCrowd; startup hopes device will help tackle COVID-19 too
Clearance follows US clinical trials that show Tel Aviv-based Sight Diagnostics' product can do complete blood count in minutes, with lab-like accuracy, using pinprick of blood
Recent comments